| Title |
Suicidality and second generation anytipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period
|
|---|---|
| Published in |
Psychopharmacology, February 2004
|
| DOI | 10.1007/s00213-004-1801-2 |
| Pubmed ID | |
| Authors |
Y Barak, I Mirecki, HY Knobler, Z Natan, D Aizenberg |
| Abstract |
Rates of attempted suicide for individuals with schizophrenia are approaching 30%. Attempted suicide is among the most potent predictors of subsequent suicide. Several studies suggest that suicide is more likely to occur in patients who are not being adequately treated or not being treated at all. An effort was made in the last decade to evaluate the antisuicide effects of pharmacological treatment in schizophrenia with emphasis on the role of the newer second-generation antipsychotics (SGA). |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | 1% |
| Australia | 1 | 1% |
| Unknown | 65 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 16% |
| Student > Ph. D. Student | 7 | 10% |
| Student > Master | 7 | 10% |
| Student > Bachelor | 7 | 10% |
| Professor > Associate Professor | 6 | 9% |
| Other | 13 | 19% |
| Unknown | 16 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 19 | 28% |
| Psychology | 11 | 16% |
| Social Sciences | 3 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
| Nursing and Health Professions | 2 | 3% |
| Other | 7 | 10% |
| Unknown | 22 | 33% |